StocksMedium•1 October 2026•
1 min read
ADARx Pharmaceuticals Raises $513.2M in IPO Following Over-Allotment
Key Facts
1ADARx Pharmaceuticals raised $513.2 million following the exercise of the over-allotment option by underwriters in its IPO.
ADARx Pharmaceuticals raised $513.2 million following the exercise of the over-allotment option by underwriters in its initial public offering. Investing.com reported that the company finalized its capital raising process after the additional share purchase option was fully utilized.
The securing of additional funds followed the exercise of the 'greenshoe' option by underwriters after the initial offering. The successful completion of the IPO and the full exercise of the over-allotment indicates positive investor sentiment toward the biotech sector amid broader shifts in global consumer confidence.